Alexander Khan

Investor Relations Contact at ABSCI CORPORATION

Finance

Consumer Services

Commercial Services

Profile

Alexander Khan is Vice President-Finance & Head-Investor Relations at Absci Corp.
Formerly, Mr. Khan worked as an Equity Research Associate at Credit Suisse Securities (USA) LLC (Broker) from 2017 to 2021 and as an Audit Senior Assistant at Deloitte & Touche LLP from 2016 to 2017.
Mr. Khan completed undergraduate education at the College of the Holy Cross (Massachusetts) in 2016.

Alexander Khan active positions

Companies	Position	Start
ABSCI CORPORATION	Investor Relations Contact	-

All active positions of Alexander Khan

Former positions of Alexander Khan

Companies	Position	End
Credit Suisse Securities (USA) LLC (Broker) Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	01/08/2021
Deloitte & Touche LLP Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services	Corporate Officer/Principal	01/12/2017

See the detail of Alexander Khan's experience

Training of Alexander Khan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alexander Khan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Credit Suisse Securities (USA) LLC (Broker) Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services	Finance
College of the Holy Cross (Massachusetts) College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Deloitte & Touche LLP Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services	Commercial Services
Absci Corp. Absci Corp. BiotechnologyHealth Technology Engages in development of cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry	Health Technology